Cargando…

Safety and tolerability of single low-dose primaquine in a low-intensity transmission area in South Africa: an open-label, randomized controlled trial

BACKGROUND: To reduce onward falciparum malaria transmission, the World Health Organization recommends adding single low-dose (SLD) primaquine to artemisinin-based combination treatment in low transmission areas. However, uptake of this recommendation has been relatively slow given concerns about wh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raman, Jaishree, Allen, Elizabeth, Workman, Lesley, Mabuza, Aaron, Swanepoel, Hendrik, Malatje, Gillian, Frean, John, Wiesner, Lubbe, Barnes, Karen I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6592007/ https://www.ncbi.nlm.nih.gov/pubmed/31234865 http://dx.doi.org/10.1186/s12936-019-2841-8

Ejemplares similares

Absence of kelch13 artemisinin resistance markers but strong selection for lumefantrine-tolerance molecular markers following 18 years of artemisinin-based combination therapy use in Mpumalanga Province, South Africa (2001–2018)
por: Raman, Jaishree, et al.
Publicado: (2019)

Understanding human genetic factors influencing primaquine safety and efficacy to guide primaquine roll-out in a pre-elimination setting in southern Africa
por: Awandu, Shehu S., et al.
Publicado: (2018)

Making data map-worthy—enhancing routine malaria data to support surveillance and mapping of Plasmodium falciparum anti-malarial resistance in a pre-elimination sub-Saharan African setting: a molecular and spatiotemporal epidemiology study
por: Kagoro, Frank M., et al.
Publicado: (2022)

Rationale for short course primaquine in Africa to interrupt malaria transmission
por: Eziefula, Alice C, et al.
Publicado: (2012)

The feasibility of malaria elimination in South Africa
por: Maharaj, Rajendra, et al.
Publicado: (2012)

The tolerability of single low dose primaquine in glucose-6-phosphate deficient and normal falciparum-infected Cambodians
por: Dysoley, Lek, et al.
Publicado: (2019)

Low-dose primaquine to reduce the transmission of P. falciparum malaria: a roadmap update
por: Chen, Ingrid, et al.
Publicado: (2014)

Pharmacovigilance for single low-dose primaquine: a practical approach
por: Poirot, Eugenie, et al.
Publicado: (2014)

Single low-dose primaquine for blocking transmission of Plasmodium falciparum malaria – a proposed model-derived age-based regimen for sub-Saharan Africa
por: Taylor, W. Robert, et al.
Publicado: (2018)

An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in Cambodia
por: Leang, Rithea, et al.
Publicado: (2016)

Is it time for Africa to adopt primaquine in the era of malaria control and elimination?
por: Mwaiswelo, Richard O., et al.
Publicado: (2022)

Serology reveals heterogeneity of Plasmodium falciparum transmission in northeastern South Africa: implications for malaria elimination
por: Biggs, Joseph, et al.
Publicado: (2017)

Pharmacokinetics of single low dose primaquine in Ugandan and Congolese children with falciparum malaria
por: Mukaka, Mavuto, et al.
Publicado: (2023)

Optimally timing primaquine treatment to reduce Plasmodium falciparum transmission in low endemicity Thai-Myanmar border populations
por: Lawpoolsri, Saranath, et al.
Publicado: (2009)

Erratum to: An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in Cambodia
por: Leang, Rithea, et al.
Publicado: (2016)

Effectiveness and cost-effectiveness of reactive, targeted indoor residual spraying for malaria control in low-transmission settings: a cluster-randomised, non-inferiority trial in South Africa
por: Bath, David, et al.
Publicado: (2021)

An assessment of the supply, programmatic use, and regulatory issues of single low-dose primaquine as a Plasmodium falciparum gametocytocide for sub-Saharan Africa
por: Chen, Ingrid, et al.
Publicado: (2015)

Genetic Analysis of Primaquine Tolerance in a Patient with Relapsing Vivax Malaria
por: Bright, A. Taylor, et al.
Publicado: (2013)

Modelling the therapeutic dose range of single low dose primaquine to reduce malaria transmission through age-based dosing
por: Hayes, Daniel Joseph, et al.
Publicado: (2017)

The reality of using primaquine
por: Burgoine, Kathy L, et al.
Publicado: (2010)

Primaquine: the risks and the benefits
por: Ashley, Elizabeth A, et al.
Publicado: (2014)

Reviewing South Africa’s malaria elimination strategy (2012–2018): progress, challenges and priorities
por: Raman, Jaishree, et al.
Publicado: (2016)

Single dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission in Cambodia: An open-label randomized trial
por: Lin, Jessica T., et al.
Publicado: (2017)

Model-based assessment of the safety of community interventions with primaquine in sub-Saharan Africa
por: van Beek, Stijn W., et al.
Publicado: (2021)

Efficacy of Single-Dose Primaquine With Artemisinin Combination Therapy on Plasmodium falciparum Gametocytes and Transmission: An Individual Patient Meta-Analysis
por: Stepniewska, Kasia, et al.
Publicado: (2020)

Safety of single low-dose primaquine in glucose-6-phosphate dehydrogenase deficient falciparum-infected African males: Two open-label, randomized, safety trials
por: Bastiaens, Guido J. H., et al.
Publicado: (2018)

Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmission
por: Graves, Patricia M, et al.
Publicado: (2015)

Primaquine or other 8-aminoquinoline for reducing P. falciparum transmission
por: Graves, Patricia M, et al.
Publicado: (2014)

Primaquine or other 8‐aminoquinolines for reducing Plasmodium falciparum transmission
por: Graves, Patricia M, et al.
Publicado: (2018)

Open-Label Crossover Study of Primaquine and Dihydroartemisinin-Piperaquine Pharmacokinetics in Healthy Adult Thai Subjects
por: Hanboonkunupakarn, Borimas, et al.
Publicado: (2014)

The Efficacy of Artesunate, Chloroquine, Doxycycline, Primaquine and a Combination of Artesunate and Primaquine against Avian Malaria in Broilers
por: SOHSUEBNGARM, Damnern, et al.
Publicado: (2014)

Primaquine-thiazolidinones block malaria transmission and development of the liver exoerythrocytic forms
por: Aguiar, Anna Caroline C., et al.
Publicado: (2017)

Pharmacokinetic Interactions between Primaquine and Chloroquine
por: Pukrittayakamee, Sasithon, et al.
Publicado: (2014)

Imported Tertian Malaria Resistant to Primaquine
por: Na, Dong Jib, et al.
Publicado: (1999)

Rational malaria chemoprophylaxis – The position of primaquine
por: Baird, J. Kevin
Publicado: (2017)

Pharmacokinetics of chloroquine and primaquine in healthy volunteers
por: Daher, André, et al.
Publicado: (2022)

Population Pharmacokinetics of Primaquine in the Korean Population
por: Lee, Woo-Yul, et al.
Publicado: (2021)

Comparative metabolism and tolerability of racemic primaquine and its enantiomers in human volunteers during 7-day administration
por: Khan, Washim, et al.
Publicado: (2023)

Responsive Sensory Evaluation to Develop Flexible Taste-Masked Paediatric Primaquine Tablets against Malaria for Low-Resource Settings
por: Ranmal, Sejal R., et al.
Publicado: (2023)

Formation primaquine-5,6-orthoquinone, the putative active and toxic metabolite of primaquine via direct oxidation in human erythrocytes
por: Fasinu, Pius S., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_902bobig4g34th146u32bra39e